SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-98-002106
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
10
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION 10-K 162990
2 GENZYME CORPORATION ANNUAL REPORT EX-13.1 400193
3 GENZYME TISSUE REPAIR ANNUAL REPORT EX-13.2 88157
4 GENZYME MOLECULAR ONCOLOGY ANNUAL REPORT EX-13.3 91581
5 SUBSIDIARIES OF THE COMPANY EX-21 1186
6 CONSENT OF COOPERS & LYBRAND LLP EX-23.1 1493
7 FINANCIAL DATA SCHEDULE 12/31/97 EX-27.1 3152
8 FINANCIAL DATA SCHEDULE DATED 13/31/96 EX-27.2 3401
9 FINANCIAL DATA SCHEDULE DATED 12/31/95 EX-27.3 2823
10 MANAGEMENT & ACCOUNTING POLICIES EX-99.1 19728
  Complete submission text file 0000950135-98-002106.txt   777133
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14680 | Film No.: 98583319
SIC: 2836 Biological Products, (No Diagnostic Substances)